Stereotaxis, Inc. Common Stock (STXS) is a publicly traded Healthcare sector company. As of November 2, 2026, STXS trades at $0.90 with a market cap of $86.43M and a P/E ratio of -4.98. STXS moved +4.34% today. Year to date, STXS is -62.82%; over the trailing twelve months it is -70.46%. Its 52-week range spans $0.81 to $3.59. Analyst consensus is strong buy with an average price target of $3.00. Rallies surfaces STXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for STXS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.90 |
| Market Cap | $86.43M |
| P/E Ratio | -4.98 |
| EPS | $-0.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.59 |
| 52-Week Low | $0.81 |
| Volume | 187.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $-1.81M |
| Net Income | $-22.32M |
| Gross Margin | -923.09% |
3 analysts cover STXS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.00.